
HIV Prevention: Access and Innovation in Latin America
Explore lenacapavir’s promising efficacy for HIV prevention through twice-yearly shots. Discuss barriers to access, including pricing strategies by Gilead Sciences and efforts from activists and governments. Learn about alternative approaches like alimatravir and the role of long-acting PrEP in combating HIV.
📥 Connect with The Well-Built Life
If you enjoyed today’s conversation, please take a moment to follow or subscribe to the channel on your favorite platform so you never miss a practical health and wellness tip.
Spreaker: Spreaker Podcast Link
Business Inquiries: Contact Us
☕ Support the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.